Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with Induction Chemotherapy in Locally Advanced Head and Neck Cancer
NCT01133678Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- May 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in squamous cell carcinoma of the head and neck (HNSCC) comparing Everolimus with Placebo (2 arms). Primary endpoint: Tumor Responses at 2 months. Started May 2010; status: terminated.
02
Drugs
everolimus
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01133678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133678.